These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21013812)

  • 41. Cryosurgery in cutaneous leishmaniasis.
    Bassiouny A
    Br J Dermatol; 1983 Nov; 109(5):617-9. PubMed ID: 6639884
    [No Abstract]   [Full Text] [Related]  

  • 42. [Note on the use of drugs with antimony base; a case of kala-azar treated with glucantime].
    GIRAUD P; BERNARD R; VINCENT P
    Arch Fr Pediatr; 1954; 11(6):659-62. PubMed ID: 13198287
    [No Abstract]   [Full Text] [Related]  

  • 43. [Adverse events related to systemic treatment using Glucantime for cutaneous leishmaniasis: a report from Tunisia].
    Mlika BR; El Aïdli S; Ben Brahim M; Badri T; Chouk S; Ben Jannet S; Marrrak H; Daghfous R; Mokhtar I; Fenniche S
    Med Trop (Mars); 2008 Oct; 68(5):499-501. PubMed ID: 19068983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The treatment of cutaneous leishmaniasis.
    Kurban AK; Farah FS; Chaglassian HT
    Dermatol Int; 1967; 6(3):168-71. PubMed ID: 5590121
    [No Abstract]   [Full Text] [Related]  

  • 45. Cutaneous leishmaniasis in mice: resistance to glucan immunotherapy, either alone or combined with chemotherapy.
    Avila JL; Biondo F; Monzón H; Convit J
    Am J Trop Med Hyg; 1982 Jan; 31(1):53-9. PubMed ID: 7058978
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oriental sore. A look at trends in and approaches to the treatment of leishmaniasis.
    Chong H
    Int J Dermatol; 1986 Dec; 25(10):615-23. PubMed ID: 3026976
    [No Abstract]   [Full Text] [Related]  

  • 47. Should we continue to indicate meglumine antimoniate as first-line treatment for cutaneous leishmaniasis in Tunisia.
    Mlika RB; Hamida MB; Hammami H; Jannet SB; Badri T; Fenniche S; Mokhtar I
    Dermatol Ther; 2012; 25(6):615-8. PubMed ID: 23210761
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alternate treatment of cutaneous leishmaniasis.
    Mutinga MJ; Mngola EN
    East Afr Med J; 1974 Jan; 51(1):68-78. PubMed ID: 4839241
    [No Abstract]   [Full Text] [Related]  

  • 49. [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
    Bourée P; Anciaux ML; Taugourdeau P
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):607-10. PubMed ID: 3003657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interferon gamma therapy for cutaneous leishmaniasis.
    Kürkçüoğlu N; Tandoğdu R
    Arch Dermatol; 1990 Jun; 126(6):831-2. PubMed ID: 2111977
    [No Abstract]   [Full Text] [Related]  

  • 51. Leishmaniasis. Currently recommended treatment.
    Selim MM; Vlasin Z; Jaroskova L
    Int J Dermatol; 1990 Jun; 29(5):318-21. PubMed ID: 2163368
    [No Abstract]   [Full Text] [Related]  

  • 52. [New Contributions To the Chemotherapy Of Infantile Kala-Azar By Concentrated Solustibosan].
    LOZANO MORALES A
    Rev Sanid; 1945 Aug; 19():529-35. PubMed ID: 21013091
    [No Abstract]   [Full Text] [Related]  

  • 53. The treatment of diffuse cutaneous leishmaniasis: a report of two cases.
    Okelo GB; Sang D; Bhatt KM
    East Afr Med J; 1991 Jan; 68(1):67-8. PubMed ID: 1647944
    [No Abstract]   [Full Text] [Related]  

  • 54. [METABOLISM OF ANTIMONY IN CHILDREN WITH VISCERAL LEISHMANIASIS TREATED WITH SOLUSURMIN. II].
    FUZAILOV IuM
    Med Parazitol (Mosk); 1964; 33():438-43. PubMed ID: 14250146
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical aspects of cutaneous leishmaniasis acquired in Texas.
    Nelson DA; Gustafson TL; Spielvogel RL
    J Am Acad Dermatol; 1985 Jun; 12(6):985-92. PubMed ID: 4008710
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical study of a focus of trichinellosis in Bucharest, with special reference to kalio-stibio-tartaric treatment].
    Ciplea A; Bubuianu G; Felberg B; Răiciulescu N; Munteanu M; Todoran F
    Fiziol Norm Patol; 1966; 12(6):549-53. PubMed ID: 5973488
    [No Abstract]   [Full Text] [Related]  

  • 57. [The level of antimony in dogs with visceral leishmaniasis treated with solusurmin].
    FUZAILOV IuM
    Med Parazitol (Mosk); 1962; 31():723-7. PubMed ID: 13945955
    [No Abstract]   [Full Text] [Related]  

  • 58. [Orally and cutaneously administered antimony compounds in therapy of mucocutaneous leishmaniasis].
    PENA CHAVARRIA A
    Bol Med Hosp Infant Mex; 1956; 13(1-2):57-61. PubMed ID: 13315566
    [No Abstract]   [Full Text] [Related]  

  • 59. Cutaneous leishmaniasis. Treatment with combined cryotherapy and intralesional stibogluconate injection.
    el Darouti MA; al Rubaie SM
    Int J Dermatol; 1990; 29(1):56-9. PubMed ID: 2158487
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma.
    Badaro R; Falcoff E; Badaro FS; Carvalho EM; Pedral-Sampaio D; Barral A; Carvalho JS; Barral-Netto M; Brandely M; Silva L
    N Engl J Med; 1990 Jan; 322(1):16-21. PubMed ID: 2104665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.